Re:Problems Found at Theranos Lab
by AndrewKemendo on Monday January 25, 2016 @01:42PM
(#10968976)
Not everything is about ROI.
Of course not everything is about ROI. However, the VC model is predicated on outsized returns. Without that they don't exist. Novelty's value to a VC is that it makes it more credible that they'll see such outsized returns.
When founding a new organization, you have a choice of making it for-profit, or non-profit. If you choose for-profit, you are making a statement about your priorities; when you take VC money, the term sheets are very clear about the ambitious ROI you are going for.
Re:Problems Found at Theranos Lab
by AndrewKemendo on Tuesday January 26, 2016 @01:17AM
(#10972108)
I think your point about profit vs non-profit is a good one.
Unfortunately I have yet to see a non-profit or FOSS bring widespread changes to the way people live and work - so we are kind of stuck for a while with this model eh?
Well, from an investor's perspective, doing anything novel is fraught with risk, and growing the value of the company is what feeds my ROI. If there is a way to grow the value without taking that risk, they ought to do it. Be novel only when necessary.